TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the "Company"), an oncology company integrating novel delivery technology with standard of care therapies, and its investigational immunotherapeutic to ...

The organizations that thrive during uncertain times are the ones who learn to keep moving even when visibility is limited.

April 01, 2026 - PRESSADVANTAGE - As life sciences companies expand globally, the need for effective communication ...

MONTREAL, April 09, 2026 (GLOBE NEWSWIRE) -- The Business Development Bank of Canada (BDC) today announced the launch of its ...

The post-pandemic bubble popped, but life sciences aren’t going anywhere. Blackstone announced Monday that it closed ...

One of the world’s leading investment firms has broken its own record with the closing of its $6.3 billion Blackstone Life ...

Achieve exceeded long-term safety study requirements and secured a manufacturing partnership, positioning for a potential 1H 2027 commercial launch if approved. Read the full analysis here.

Dialogue continues with European Medicines Agency (EMA) to advance the development program of oral blarcamesine in early Alzheimer’s ...

Of the 11 companies participating in the spring cohorts of the Drive program run by MassBio and SCbio, eight have locations ...

The U.S. Patent and Trademark Office (USPTO) on Monday held the first of three planned Patent Trial and Appeal Board ...

Joseph Kadlec and Douglas Gray of Troutman Pepper Locke LLP discuss how life sciences companies can position themselves for M ...

Wave Life Sciences has plummeted after two Wall Street firms cut price targets following updated trial data for the company's ...